AVR 4.08% $12.49 anteris technologies ltd

Ann: Preliminary Final Report for period to 31 December 2018, page-26

  1. 27,364 Posts.
    lightbulb Created with Sketch. 1777
    I thought it was $2M, therefore, thinking it was finalized but it was only $1M for 12 months so it hasn't been secured and the decision will be due in a few months.....

    In April 2018, Admedus signed a Memorandum of Understanding with shareholder Star Bright Holding Limited (“Star Bright” for an investment of $18 million in a new company who will own Admedus Vaccines Pty Limited, providing a 60% equity interest in this new company. As part of this arrangement Star Bright paid Admedus Vaccines $1 million over two instalments which secured a twelve-month exclusivity period to finalise the terms of an agreement. If this agreement goes ahead the $1 million will convert to capital forming part of the $18 million investment.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.